Checkpoint Therapeutics (CKPT) Cash Money per Share

checkpointtx.com - graphic logo of issuer CKPT

Global political instability and sanctions create risks for Checkpoint Therapeutics (CKPT) component procurement, which is confirmed by the cash per share analysis using chart data from GURU.Markets. The value 0.39 reflects the baseline level of the metric. Checkpoint Therapeutics (CKPT) develops budget-friendly alternatives to expensive drugs for solid tumors, although FDA inspections of a third-party plant have temporarily limited the commercial implementation of immuno-oncology antibodies.

CKPT Checkpoint Therapeutics, Inc: Cash per Share in the range 07/04/2022 - 06/07/2025

Analytical breakdowns for Checkpoint Therapeutics (CKPT)

- cash availability and cash flow indicators:
General company analysis:Checkpoint Therapeutics - CKPT
Product sample of Checkpoint Therapeutics Inc

This indicator determines the volume of liquid reserves per security, reflecting the actual value of the issuer's safety cushion. The metric measures the company's ability to fund operating activities without incurring external debt. By analyzing the cash per share structure, an investor can see the rate of capital burn during the pre-commercial stage. For Checkpoint Therapeutics (CKPT), this is critical when preparing for aggressive expansion following FDA approval. The trend of this indicator determines the business's survival horizon before reaching break-even.

Competing companies

Cash Funds per Single Share ONC (BeiGene Corp)|Cash per Single Share HALO (Halozyme Therapeutics, Inc.)|Cash per Share Revolution Medicines, Inc. (RVMD)|Cash per Share AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cash on Hand per Share|URGN - Cash Funds per Share|Bicara Bio - Cash Calculated per Single Share|PSNL: Cash per Share|Cash Funds per Single Share ERAS|Cash per Single Share DCTH|Cash on Hand per Share Y-mAbs Therapeutics Inc YMAB|Cash per Share AURA|CADL (Candel Therapeutics, Inc.) - Amount of Cash per Share|Cash Funds per Share Accuray Inc ARAY|Cash Funds Calculated per Share SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Cash per Share|Cash on Hand per Share Citius Oncology|HURA: Cash per Share|Cash Money per Share TARA (Protara)|FATE (fatetherapeutics.com) - Cash per Share|Cash on Hand per Share Aadi Bioscience WHWK|Cash per Share TCRX|CSBR - Cash on Hand per Share|XBiotech - Cash per Single Share|CEL-SCI Corporation (CVM) - Cash on Hand per Share|OSTX - Cash Funds per Share|Cash on Hand per Share Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Cash per Single Share|ANL (Adlai Nortye Ltd) - Cash Funds per Share|Cash per Single Share VERU|Tempest Therapeutics (TPST) - Cash Funds Calculated per Share|Cash per Share XLO|Cash per Single Share Renovaro RENB|Cash per Share MURA (Mural Oncology PLC)|KAPA - Cash per Single Share|OnKure Therapeutics - Cash per Share|w2.cytomed.sg - Cash Calculated per Single Share|Curis Corp (CRIS) - Cash Funds per Share|Cash on Hand per Share Apollomics Corp (APLM)|Cash Funds per Share Tharimmune|Cash per Share advanbiomed.com|Cash Funds per Share Genprex, Inc (GNPX)|Cash Funds Calculated per Share Calidi Biotherapeutics, Inc.|Cash per Share SBFM (Sunshine Biopharma Inc.)|XBIO - Cash per Single Share|SLRX: Cash per Single Share|Amount of Cash per Share PPBT (Purple Biotech Ltd.)|AONC: Cash per Share|Cash on Hand per Share BeOne Medicines (BGNE)|ELEV (Elevation Oncology Inc.) - Cash per Share|icadmed.com (ICAD) - Cash Funds Calculated per Share|Cash per Share IKNA|NTBL (Notable Labs) - Amount of Cash per Share|Cash per Share VIRX (Viracta Therapeutics)|Cash Funds Calculated per Share MorphoSys AG (MOR)|NAYA Biosciences Corp - Cash per Share|Cash on Hand per Share ascentage.com